1. Home
  2. PSN vs LEGN Comparison

PSN vs LEGN Comparison

Compare PSN & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Parsons Corporation

PSN

Parsons Corporation

HOLD

Current Price

$62.74

Market Cap

9.2B

Sector

Technology

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.85

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSN
LEGN
Founded
1944
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.2B
5.9B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PSN
LEGN
Price
$62.74
$22.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
13
Target Price
$85.29
$69.58
AVG Volume (30 Days)
2.2M
2.6M
Earning Date
11-05-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
7.02
N/A
EPS
2.17
N/A
Revenue
$6,494,748,000.00
$909,045,000.00
Revenue This Year
N/A
$68.83
Revenue Next Year
$4.29
$51.27
P/E Ratio
$28.65
N/A
Revenue Growth
N/A
74.75
52 Week Low
$54.56
$21.19
52 Week High
$97.91
$45.30

Technical Indicators

Market Signals
Indicator
PSN
LEGN
Relative Strength Index (RSI) 31.79 32.41
Support Level $60.00 $21.19
Resistance Level $62.21 $28.97
Average True Range (ATR) 2.76 1.19
MACD -0.41 0.01
Stochastic Oscillator 11.14 19.41

Price Performance

Historical Comparison
PSN
LEGN

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: